OMM-1Homo sapiens (Human)Cancer cell line

Also known as: Omm1, OMM1

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_6939
SpeciesHomo sapiens (Human)
Tissue SourceHypodermis[UBERON:UBERON_0002072]

Donor Information

Age74
Age CategoryAdult
SexMale

Disease Information

DiseaseUveal melanoma
LineageEye
SubtypeUveal Melanoma
OncoTree CodeUM

DepMap Information

Source TypeAcademic lab
Source IDACH-002017_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleGNA11p.Gln209Leu (c.626A>T)Unspecified-PubMed=22236444

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
11,12
D16S539
9
D18S51
13,14
D21S11
30,30.2
D3S1358
14,17
D5S818
11
D7S820
13
D8S1179
10,16
FGA
20
Penta D
9,12
Penta E
5,7
TH01
7
TPOX
8,9
vWA
19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Roman-Roman S.

Mol. Oncol. 8:1508-1520(2014).

Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity.

Salvi S., Truini M., Poggi A., Pfeffer U.

Eur. J. Cancer 49:3353-3365(2013).

Genetic and molecular characterization of uveal melanoma cell lines.

Bernatchez C., Wardell S., Bastian B.C., Woodman S.E.

Pigment Cell Melanoma Res. 25:182-187(2012).

Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.";

White J.S., Becker R.L., McLean I.W., Director-Myska A.E., Nath J.

Cancer Genet. Cytogenet. 168:11-21(2006).

Establishment and characterization of primary and metastatic uveal melanoma cell lines.

van Drunen E., Vuzevski V., de Jong P.T.V.M., Luider T.M.

Int. J. Cancer 66:380-387(1996).